CXCL12-PLGA/Pluronic Nanoparticle Internalization Abrogates CXCR4-Mediated Cell Migration

Area of Science:

• Biomedical Engineering
• Immunology
• Nanotechnology

Background:

• Chemokine-induced chemotaxis is crucial for immune cell trafficking and cell migration.
• CXCL12/CXCR4 signaling plays a significant role in cancer progression and metastasis.
• Current CXCR4-targeting strategies involve small molecules or peptides, but a different approach was explored.

Purpose of the Study:

• To develop and evaluate novel chemokine-mimetic nanoparticles for reducing CXCR4-mediated cell migration.
• To investigate the potential of CXCL12-decorated nanoparticles as antagonists of chemotaxis.

Main Methods:

• Poly(lactic acid-co-glycolic acid) (PLGA)/Pluronic F127 nanoparticles were fabricated using microfluidics-assisted nanoprecipitation.
• Nanoparticles were functionalized with streptavidin and loaded with biotinylated CXCL12.
• THP-1 monocytes were used to assess nanoparticle toxicity, cytokine release, internalization, and effects on cell migration.

Main Results:

• The CXCL12-decorated nanoparticles were found to be non-toxic and did not induce inflammatory cytokine release.
• Nanoparticle internalization correlated with CXCR4 expression levels.
• Pre-incubation with these nanoparticles significantly reduced CXCR4-positive cell migration, antagonizing CXCL12's chemotactic effect.

Conclusions:

• Biodegradable and immune-compatible chemokine-mimetic nanoparticles can effectively reduce cell migration.
• This approach presents a novel strategy for antagonizing chemotaxis with potential applications in cancer therapy and inflammation management.